On ECHEMI
Home > Drugs > Idarubicin hydrochloride Registered Holders
Idarubicin hydrochloride structure

Idarubicin hydrochloride structure

Idarubicin hydrochloride

Idarubicin hydrochloride is an anthracycline antileukemic drug. It inhibits the topoisomerase II interfering with the replication of DNA and RNA transcription.

Find 12 Related Holders

Shandong Newtime Pharmaceutical Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    2001-03-30
  • Country:

    China China
  • Address:

    No. 1 North Outer Ring Road, Fei County, Shandong
  • Tax NO.:

    9137130072755352X1
  • Registered Funds:

    358.238 million yuan
  • Website:

  • Email:

Suzhou Erye Pharmaceutical Co., Ltd.
China China

API Registration Country

API Inactive
  • Founded in:

    1981-04-13
  • Country:

    China China
  • Address:

    No. 2, Dongqiao Anmin Road, Huangdai Town, Xiangcheng District, Suzhou City
  • Tax NO.:

    913205001377026284
  • Registered Funds:

    300 million yuan
  • Website:

  • Email:

  • 1
  • 2
  • Go to Page Go
Recommended Suppliers of Idarubicin hydrochloride
View 60 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.